THEORETICAL BASIS OF APPLICATION OF STEM CELLS TRANSPLANTATION IN CLINICAL PRACTICE
DOI:
https://doi.org/10.30890/2709-2313.2024-32-00-002Ключові слова:
hemopoetic stem cell, mesenchymal stem cell, progenitor stem cell, regenerative medicine, stem cell therapyАнотація
Stem cell transplantation is becoming a more common procedure in the treatment of pathological states and a number of different diseases.Goal of Research. Analyze the information about the stem cell (SC) biology (description, properties) offering greatMetrics
Посилання
Spradling A, Drummond-Barbosa D, Kai T. Stem cells find their niche Nature. 2001;414:98–104.
Bianco P., Riminucci M., Gronthos S., Robey P.G. Bone marrow stromal stem cells: nature, biology and potential applications.Stem Cells. 2001;19180 – 192.
Kuchartschuk OL, Radtchenko VV, Sirman VM. Stvolovye kletky; eksperement, teoriya, klinika. KRS- melytchynskie technologiy. 2004:504
Morrison SJ, Shah NM, Anderson DJ. Regulatory vechanisms in stem cells biology. Cell. 1997;88:287–298.
Fuch E, Segre JA. Stem cells: A new lease on life. Cell. 2000;100:143–155.
Weissman IL. Stem cells: Units of development, units of regeneration, and units inevolution. Cell. 2000;100:157–168.
Yosida K, Chambers I, Nicholos J. Maintenance of the pluripotential phenotype of embryonic stem cells through direct activation of gr 130 signaling pathways. Mech. Dev. 1994;45:163-171.
Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145-1147.
Reubinoff BE, Pera M F, Fong CY, Trounson A, Bongso A. Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro. Nat. Biotechnol. 2000;18:399–404.
Itskovitz-Eldor J, Schulding M, Karesenti D, Eden A, et al. Differentiation of human embryonic stem cells into embryoid bodies comprising the three embryonic germ lauers. Mol. Med. 2000;5:88 – 95.
Schuldiner M, Yanuca O, Istkovitz-Eldor J, Melton D, Benvenistry N. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc. Natl. Acad. Sci. USA. 2000;907:11307-11312.
Odorico JS, Kaufman DS, Thomson JA. Multilineage differentiation from human embryonic stem cell lines. Stem Cells. 2001;19:193–204.
Kaufman DS, Levis Rl, Auerbach R, et al. Directed differentiation of human
Embryonic stem cells into hematopoietic colony forming cells. Blood. 1999:94:34 p.
Kunkel T. A., Bebenek K. DNA replication fidelity.Annu. Rev. Biochem. 2000;69:497–529.
Benirschke K., Kaufmann P. Pathology of the human placenta (3rd edition).New York: Springer-Verlag, 1995.
Clarke D. L., Johansson C. B., Wilbertz J., Veress B. et al. Generalized potential of adult neural stem cells. Science. 2000;288:1660–1663.
Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, et al. Purified Hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat. Med. 2000;6:1229-1234.
Galli R., Borello U., Gritti A., Minasi M., et al. Skeletal myogenic potential of human and mouse neural stem cells.Nat. Neurosci. 2000;3:986–991.
Ferrari G., Cusella-DeAngelis G., Coletta M., Paolucci E. et al. Muscle regeneration by bone marrow-derived myogenic progenitots. Science. 1998;279:1528 –1530.
Kondo T, Raff M. Oligodendrocyte precursor cells reprogrammed to become multipotentsal CNS stem cells.Science. 2002;289:1754-1757.
Woodbury D, Schwarz E, Prockop D, et al. Adult rat and human bone marrow stromal cells differentiate into neurons. J. Neurosci. Res. 2000;61:364-370.
Strauer B. E., Kornowski R. Stem cell therapy in perspective. Circulation. 2003;107:929–934.
Orlic D, Hill JM, Arai AE. Stem cells for myocardial regeneration. Circ. Res. 2002;91:1092–1102.
Osawa M., Hanada K., Hamada H., Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science. 1996;273:242–245.
Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, et al. Neovascularization of ischtmic myocfrdium by human bone marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 2001;7:430-436.
Orlic D, Fischer R, Nishikava A. Pbrification and characterization of heterogeneous pluripotent hematopoetic stem cell populations expressing high levels of c-kit receptor. Blood. 2003;82:762–769.
Orlic D, Kajstura J, Chimenti S, Limana F, et al. Mobilized bone marrow cells repair the infracted heart, improving function and survival. Proc. Natl. Acad. Sci. USA. 2001;98:10344-10349.
Stamm C, Westphal B, Kleine HD, Petzsch M, et al. Autologous bone-marrow stem cell transplantation for myocardial regeneration. Lancet. 2003:361:45-46.
Goodell M. A., Brose K., Paradis G., Conner A. S., Mulligan R. C. Isolation and functional properties of murine hematopoietic stem cellsthat are replicating in vivo. J. Exp. Med. 1996;183:1797–1806.
Genchi A, Brambilla E, Sangalli F, Radaelli M, Bacigaluppi M, Furlan R, Andolfo A, Drago D, Magagnotti C, Scotti GM, Greco R, Vezzulli P, Ottoboni L, Bonopane M, Capilupo D, Ruffini F, Belotti D, Cabiati B, Cesana S, Matera G, Leocani L, Martinelli V, Moiola L, Vago L, Panina-Bordignon P, Falini A, Ciceri F, Uglietti A, Sormani MP, Comi G, Battaglia MA, Rocca MA, Storelli L, Pagani E, Gaipa G, Martino G. Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study. Nat Med. 2023 Jan;29(1):75-85. doi: 10.1038/s41591-022-02097-3. Epub 2023 Jan 9. PMID: 36624312; PMCID: PMC9873560.
Caplan AI. Mesenchymal stem cells. J.Ortho. Res.1991:9:641-650.
Goshima J, Goldberg V, Paradis G. Isolation and functional properties of murine hematopoietic stem cells that are replicfting in vivo. J. Exp. Med.2006;183:1797–1806.
Cheng L, Qasba P, Vanguri P. Human mesenchymal stem cells support
megekaryocyte and pro-platelet formation from CD34+ hematopoietic progenitor cells. J. Cell. Physiol. 2000;184:58-69.
Pittenger M.F., Thiede M.A. In vitro maintenance in hematopoietic stem cells. U. S. Patent. 2002:6,030.836.
Stem cell therapies for neuromuscular diseases, Partridge TA, Acta Neurol Belg. 2004 Dec; 104(4):141-7
Albu S, Kumru H, Coll R, Vives J, Vallés M, Benito-Penalva J, Rodríguez L, Codinach M, Hernández J, Navarro X, Vidal J. Clinical effects of intrathecal administration of expanded Wharton jelly mesenchymal stromal cells in patients with chronic complete spinal cord injury: a randomized controlled study. Cytotherapy. 2021 Feb;23(2):146-156. doi: 10.1016/j.jcyt.2020.08.008. Epub 2020 Sep 25. PMID: 32981857.
Muraglia A., Cancedda R., Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in an hierarchical model. J. Cell Sci. 2000;13:1161–1166.
Young HE, Mancini ML, Wringht RP. Mesenchymal stem cells reside within connective of many organs. Dev. Dyn. 2005;45:137–171.
Caplan A. I., Boyan B. D. Endochonadral bone formation: The lineage cascade. In Bone: Mechanisms of bone development and growth. – CRC Press. Boca Raton, Florida B. Hall, 1994.
Wakatani S., Goto T., Pineda S., Young R. et al. Mezenchymal cell-based repair of large, full-thickness defects of articular cartilage. J. Bone Joint Surg. Am. 1994;76:579-592.
Kim YJ, Ahn HJ, Lee SH, Lee MH, Kang KS. Effects of conditioned media from human umbilical cord blood-derived mesenchymal stem cells in the skin immune response. Biomed Pharmacother. 2020 Nov;131:110789. doi: 10.1016/j.biopha.2020.110789. Epub 2020 Oct 23. PMID: 33152947.
Zhang W, Ling Q, Wang B, Wang K, Pang J, Lu J, Bi Y, Zhu D. Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes. Stem Cell Res Ther. 2022 Aug 8;13(1):406. doi: 10.1186/s13287-022-02974-1. PMID: 35941696; PMCID: PMC9358877
Richards M, Huibregtse B, Caplan A, Goulet J. Marrowderived progenitor cell injections enhance new bone formation dbring distraction. J. Orthop. Res. 2009;17:900-908.
Johnstone B, Yoo J. Autologous mesenchymal progenition cells in articular cartilage repair. Clin. Orthop. 2000;81:117-143.
Almeida-Porada G, Porada C, Tran N, Zanjani E. Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later points after transplantation. Blood. 2000;95:3620-3627.
Lu J, Shen SM, Ling Q, Wang B, Li LR, Zhang W, Qu DD, Bi Y, Zhu DL. One repeated transplantation of allogeneic umbilical cord mesenchymal stromal cells in type 1 diabetes: an open parallel controlled clinical study. Stem Cell Res Ther. 2021 Jun 10;12(1):340. doi: 10.1186/s13287-021-02417-3. PMID: 34112266; PMCID: PMC8194026.
Bushby K, Finke R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al. DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2010; 9(1):77–93. doi: 10.1016/S14744422(09)70271-6. Epub 2009 Nov 27.
Davies KE, Nowak KJ. Molecular mechanisms of muscular dystrophies: old and new players. Nat Rev Mol Cell Biol. 2006 Oct; 7 (10): 762–73. Epub 2006 Sep 13.
Marshak DR, Gardner RL. Stem cells Biology. – Gold Spring Harbor: Laboratory Press. 2002:544 p.
Varizini H, Dragowska W, Thomas T. Evidence for a mitotic clock in human hematopoietic stem cells; Loss of telomeric DNAwith age. Proc. Natl. Acad. Sci. 2001;91:9857–9860.
Lobyntseva GS, Gladkikh YV, Lobyntsev DV, Gladkikh VY. Human embryonal hemopoietic stem cells (Theory and clinical practice): Naukova dumka:2004: 165 p.
Опубліковано
Як цитувати
Номер
Розділ
Ліцензія
Авторське право (c) 2024 Автори
Ця робота ліцензується відповідно до Creative Commons Attribution 4.0 International License.
